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Summ- Porphvnn metabolism was studied in 21 children of both sexes suffering from acute lymphoblastic
leukaemia (ALL) and 34 adult patients of different ages and sexes suffering from ALL (n = 14). non-
Hodgkin's lyxmphoma (NHL). n = 14. or Hodgkin's disease (HD). n = 6. In addition. two groups of healthy
children (n= 14). and adults (n= 17) were studied for comparison. It was apparent from this studv that the
activity of uroporphyrinogen-l-synthetase (URO-1-S. E.C. 4.3.1.8) was highly significantly activated in the
blood of children, while the activities of blood 5-aminolevulinic acid dehydrase (E.C. 4.2.1.24) and ferro-
chelatase (E.C. 4.99.1.1.). as expressed by protoporphyrin haem ratio, were inhibited in those children. Also.
free erythrocyte total porphyrins were increased. while the haem content was reduced. The concentrations of
5-aminolevulinic acid, coproporphyprin and uroporphyrin were increased in the urine of children with ALL.
On the other hand, some dramatic changes were found in porphynrn metabolism in adult patients suffering
from ALL, NHL and HD. The aforementioned disturbances were discussed in the light of some factors which
may affect the enzymatic activities in the synthesis of porphyrins.
Porphyrin metabolism has received a great deal of attention
over the last two decades since the realisation that certain
porphyrins are accumulated in some malignant tumours.
Therefore, the haem biosynthesis pathway may be disturbed
in patients suffering from such malignancies. The present
study addresses the question of whether porphyrin meta-
bolism is perturbed in certain malignant diseases such as
acute lymphoblastic leukaemia. non-Hodgkin's lymphoma
and Hodgkin's disease.
Relatively little work on haem synthesis in erythroleu-
kaemia has been published in the relevant literature. During
the induction of Friend erythroleukaemic cells in cultures, it
was observed that porphobilinogen deaminase activity began
to increase after 48 h from induction with dimethyl sulfoxide.
The cellular growth medium contained traces of protopor-
phyrin. but not of other porphyrins. Also, the enzymes of
haem synthesis except ferrochelatase were induced by butyric
acid (Rutherford et al., 1979). Recently, Malik and Lugaci
(1987) observed that endogenous porphyrin biosynthesis in
Friend erythroleukaemic cells was induced by supplementa-
tion of 5-aminolevulinic acid.
5-aminolevulinic acid dehydrase activity is markedly higher
in reticulocytes than in erythrocytes. This increase in activity
has been demonstrated during erythroid differentiation of
Mouse Friend Virus transformed erythroleukaemia cells
(Sassa. 1979) and human K562 cells (Hoffman et al.. 1980).
Also, Chang and Sassa (1985) found increased ALA-D activ-
ity in K562 cells incubated for 5 days with either butyric acid
or SeO,.
As early as 1963, Vannotti and Jeunet reported that ALA
could be converted to porphyrins in leukocytes isolated from
patients with acute leukaemia, whereas in leukocytes from
other patients ALA was converted only to porphobilinogen.
This work was confirmed by the studies of Walters et al.
(1967) who found that immature cells from patients with
acute leukaemia could utilise ALA and protoporphyrin for
haem synthesis. whereas leukocytes from healthy adults
lacked this capacity.
In infants with acute lymphoblastic leukaemia associated
with prophyria cutanea tarda, plasma ALA was elevated
3-fold and erythrocyte ALA-D activity was diminished
between 30-40% (Stella et al.. 1988).
Epstein et al. (1983) observed that erythrocyte URO-1-S
activity in patients with lymphatic proliferative disease.
including patients with chronic lymphatic leukaemia and well
differentiated lymphoma. patients with histiocytic lyxmphoma.
patients with poorly differentiated lymphoma and patients
with Hodgkin's disease. was higher than the corresponding
activity in controls. These authors observed abnormally high
concentration of porphyrins in the erythrocytes of a few
patients examined. This may indicate an overall increase in
the haem synthetic pathway.
Materials and methods
Twenty-one children with acute lymphoblastic leukaemia. 14
adult patients with acute lymphoblastic leukaemia. 14 adult
patients with non-Hodgkin's lymphoma and six adult
patients with Hodgkin's disease were the subjects of the
present study. Also. 14 healthy children and 17 healthy
adults were used as control groups for comparison. All
groups of patients and controls consisted of males and fe-
males. Fasting heparinised venous blood samples were with-
drawn from controls and patients. and at the same time,
urine samples were collected from them.
The assay of erythrocyte 5-aminolevulinic acid dehydrase
and uroporphyrinogen-l-synthetase was carried out on whole
blood samples (in which hematocrit values were determined)
according to the method of Weissberg et al. (1971) and
Piepkorn et al. (1978) respectively. Free erythrocyte total
porphyrin concentration was also estimated in whole blood
by the method described by Piomelli (1973). Blood protopor-
phyrin and haem contents were determined according to the
method of Labbe et al. (1979). Urinary coproporphyrin and
uroporphyrin were estimated by the method of Talman
(1958). whereas the concentration of urinary 5-aminolevulinic
acid and porphobilinogen was determined by the method of
Tomokuni and Ogata (1972) and Rimington (1971) respec-
tively. Urinary creatinine concentration was determined
according to the method of Van Pilsum and Bovis (1957).
Statistical analyses of the results were performed according
to the standard methods.
Results
As can be seen from Table I. there are highly significant
(P<0.001) elevations in the concentrations of ALA. copro-
prophyrin and uroporphyrin in the urine of the children with
ALL when compared with the corresponding values in the
control group. At the same time, the increase in the concen-
tration of PBG in the urine of ALL patients is not significant
(P>0.05).
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Table I Urinary concentrations of 5-aminolevulinic acid (ALA) and porphobilinogen
(mg g-' creatinine) as well as coproporphyrin and uroporphyrin (pg g- creatinine) of
control children and children with lymphoblastic leukaemia (ALL)
Item ALA PBG Coproporph!vrin Uroporphyrin
Control
Mean s.d. 0.32± 0.07 9.3± 2.4 7.6±2.2 1.6±0.5
No. 13 13 11 13
ALL
Mean s.d. 0.65± 0.26a 10.2±4.3 46.2 30a 9.6± 5.5a
No. 19 18 16 17
No. = number of cases; aHiIghy significant (P<0.001).
The concentration of urinary ALA is significantly (P<0.01)
increased in adult patients suffering from ALL; however, the
increase is insignificant in adult patients suffering from either
HD or NHL (Table II). The mean concentration of PBG is
significantly increased in the urine of adult patients suffering
from ALL, HD and NHL nearly to the same extent being
about 1%1A times the corresponding mean control value. A
comparable increase in the concentration of urinary copro-
porphyrin is observed. but the extent of that increase in
patients with ALL or NHL is higher than the increase in
patients with HD. However, the elevations observed in the
concentration of urinary uroporphyrin for ALL and NHL
are not significant. Furthermore. urinary uroporphyrin is
insignificantly decreased in adults suffering from HD (Table
II).
According to the results of Table III. there is a small but
significant inhibition in blood ALA-D activity of children
suffering from ALL. while a highly significant elevation in
the activity of blood URO-1-S of these children is observed.
At the same time, the activity of ferrochelatase, as monitored
by the protoporphyrin haem ratio, is observed to be decreas-
ed in children suffering from ALL although the increase in
blood protoporphyrin is not significant (Table III). More-
over, a significant increase in the concentration of free total
porphyrins in the blood of children with ALL is observed
when compared with the control value (Table III). Also, the
protoporphyrin of the blood is insignificantly increased while
the haem content is highly significantly diminished in those
children with ALL.
As shown from Table IV. the activity of blood ALA-D is
decreased in adult patients with ALL, NHL and HD. The
average activities in the three groups of patients are nearly
the same.
The mean activities of URO-1-S in the blood of all groups
of adult patients are elevated than the average control value;
the elevation being highly significant in both ALL and NHL
patients and significant in HD group (Table IV). Ferrochela-
tase activity, as expressed by the protoporphyrin'haem ratio,
is lowered in ALL patients and insignificantly diminished in
NHL adult patients while its activity is significantly increased
in HD adult patients.
The concentration of blood total porphvrins is elevated in
all adult patients with ALL. NHL and HD. However, the
concentration of blood protoporphynrn in both ALL and
NHL patients is apparently similar to the control mean
value, but in HD patients a high decrease is observed (Table
IV). Moreover, the haem content of ALL patients is highly
significantly diminished while in patients with NHL and HD
it is significantly decreased when compared with the control
value (Table IV).
Discussion
The present results indicate that the free erythrocyte por-
phyrins are significantly increased in children with ALL and
in adults with ALL, NHL and HD: this means that por-
phyria may be a finding accompanying ALL. NHL and HD.
Although the porphyrias have long been recognised as
disorders of haem biosynthesis. it has become apparent that
each type results from a partial deficiency of one or more of
enzymes of haem biosynthetic pathway. Furthermore. the
accumulation of haem precursors, ALA and PBG. within the
cells is a reliable indicator of a disturbance of haem synthesis
even when, as in several haematological disorders, it is not
accompanied by detectable increases in porphyrin excretion.
In both children and adult patients with ALL a high
elevation of urinary ALA was found (Tables I and II) but
the increase in urinary ALA in adult patients with NHL and
HD was insignificant. At the same time, unrnary PBG con-
centration of children with ALL does not significantly differ
from the corresponding level of control children, while its
concentrations are elevated in all adult patients. Some under-
standing of the factors that determine the disturbances of
porphyrins and haem precursors can be interpreted in terms
of enzyme activity within the body.
The results of the present work are in agreement with the
findings of Epstein et al. (1983) who observed an abnormally
high concentration of porphyrins in the erythrocytes of some
patients with chronic and acute myeloid leukaemia. These
authors attributed this porphyria to overall increase in haem
biosynthetic pathway.
Table H Urinary concentrations of5-aminolevulinic acid (ALA) and porphobilinogen
(PBG) (mg gm-', creatinine) as well as coproporphyrin and uroporphyrin (yggm-'
creatinine) of control adults and adults with acute lymphoblastic leukaemia (ALL).
non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD)
Item ALA PBG Coproporphvrin U-roporphkvrin
Control
Mean±s.d.
No.
0.24±0.06 4.3± 1.5
13 15
10.9±4.5
10
3.7± 2.0
11
ALL
Mean+s.d. 0.33±0.08b 6.4±2.4b 28.5± 19 3b 4.3±2.1
No. 13 11 11
NHL
Mean±s.d. 0.27±0.06 6.7±2.7b 31.9+13.6a 4.7±2.2
No. 13 14 12 11
HD
Mean s.d. 0.35±0.16b 6.2± 0.9b 22.5± 12.3b 2.8± 0.8
No. 6 5 5 4
No. = number of cases. aHighly significant (P<0.001). bSignificant (P<0.05).PORPHYRIN METABOLISM IN SOME MALIGNANT DISEASES 411
Table ItI Blood activities of 5-aminolevulinic acid dehydrase (ALA-D) and uroporphynrnogen-l-synthetase
(URO-1-S) aswell asconcentrationsoftotalporphyrins, protoporphynn,haemandprotoporphyrin:haem ratio
in control children and children with acute lymphoblastic leukaemia (ALL)
ALA-D URO-l-S Totalporph-rins Protoporphkyrin Haem Protoporphkrnn
Item (units)c' (zits)d (j.g%) (pmol) (mob) haem
Control
Mean±s.d. 29.3±8.5 17.4±5.2 23.8±5.1 (30±7) 107 (5±1) 10' 6.2±1.8
No. 10 14 12 12 12 11
ALL
Mean±s.d. 23.4±7.9a 32.8±16.8b 36.8±18.3k (38±18) 10- (4±1) 10- 10.9±5. a
No. 17 18 15 17 21 17
No. = number of cases. aSignificant (P<0.05). bHighly significant (P<0.001). (Units) = i.mol 5-
aminolevulinic acid utilised per minute per ml erythrocytes. (Units)d = nmol porphyrin formed per ml
erythrocytes per hour.
Table IV Blood activities of 5-aminolevulinic acid dehydrase (ALA-D) and uroporphyrinogen-l-synthetase
(URO-1-S) aswell as total porphyrins, protoporphyrin, haem and protoporphyrin haem ratio in control adults
and adults with acute lymphoblastic leukaemia (ALL), non-Hodgkin's lymphoma (NHL) and Hodgkin's
disease (HD)
ALA-D URO-l-S Totalporphkrins Protoporphkrin Haem Protoporphkrin
Item (unitsj' (UnlitS)d (glg%i (ptnol) (mol) haem
Control
Mean±s.d. 31.0±7.4 16.4±4.1 20.9±7.5 (51±22) 10-' (6±2) 10- 8.1±3.2
No. 17 14 16 15 17 15
ALL
Mean±s.d. 22.9±9.3a 36.7±20.3a 41.0±21.0' (42±14) 10- (4±1) 10- 10.9±4.3a
No. 13 13 11 13 12 11
NHL
Mean±s.d. 24.7±9.2' 33.2± 14.6b 42.5±13 5' (56±19)' 10- (5±2)' 10- 11.2±4.8
No. 12 13 11 10 11 8
HD
Mean±s.d. 20.5±8.8a 27.9± 15.3a 31.0± 11.5 (23±7)a 10- (5± )I 10- 4.7±1.la
No. 6 5 5 5 6 5
No. = number of cases. 'Sigficant (P<0.05). bHighly significant (P<0.001). (Units)' = g±mol 5-
aminolevulinic acid utilised min ml erythrocytes. (Ulnits)d = nmol porphyrin formed ml erythrocytes h.
As it is apparent from Tables III and IV that there is a
significant inhibition in ALA-D activities in both children
and adults with ALL and in adults with NHL and HD
compared with their corresponding control values. These
results are similar to the previous findings in a group of
patients suffering from ALL in addition to infantile pro-
phyria cutanea tarda where the activity of ALA-D was dimi-
nished between 30-40% (Stella et al.. 1988). However, in
another study. ALA-D activity was found to be markedly
elevated in human K562 erythroleukaemia cells (Hoffman et
al.. 1980). Decreased erythrocyte ALA-D activity in both
children and adult patients is accompanied by the findings
that anaemia is common in these patients.
In the present study. there are significant elevations in
erythrocyte URO-1-S activity in children with ALL and adult
patients with ALL. NHL and HD. These findings are in
agreement with several previous studies (Sassa. 1976: Fotouh,
1990). This elevation was attributed to the increased lympho-
cyte and blast cells count in peripheral blood of these
patients, since URO-1-S is an intracellular enzyme and it is
not secreted into the plasma (Elder, 1980). In this connection,
Epstein et al. (1983) assumed that the high erythrocyte URO-
I-S in patients with lympholiferative disease is the result of
high URO-1-S activity in the erythroid precursors in the bone
marrow.
The presence results clearly show abnormal changes in
porphyrin biosynthesis in children with ALL and these
changes may be attributed to abnormalities of the enzymes of
haem biosynthetic pathway. It is observed that protopor-
phyrin concentration is insignificantly increased concomitant
with a marked decrease in the haem content. These abnor-
malities could be attributed to the inhibition of haem synthe-
tase activity and or insufficiency of iron as previous authors
found inhibition of this enzyme in patients with ALL (Labbe
et al., 1979). Similar findings in other diseases, in which
porphyria prevalent. e.g. lead poisoning, were observed by
San Martin de Viale et al. (1976), who found a direct inhibi-
tory effect of protoporphyrin on the enzyme system of haem
pathway., this inhibition had resulted in the accumulation of
the urinary ALA, PBG and coproporphyrin as well as uro-
porphyrin.
In leukaemia and lymphatic adult patients. there are some
dramatic changes in the porphyrin metabolism, where signi-
ficant decreases in haem content were observed in all patients
(Table IV). On the other hand, the changes in protopor-
phyrin concentrations are not parallel to the changes in
haem; however, the erythrocyte total porphyrins are increas-
ed in all patients. These disturbances could reflect compar-
able changes in the enzymatic activities in tissues synthesising
porphyrins. This indicates both plentiful substrate availability
at the beginning of the porphyrin biosynthetic chain and a
block at the end of the pathway, which result in accumula-
tion of porphyrins in porphyrin synthesising tissues and
according in blood and urine.
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